Moreno-SanJuan, S.; Puentes-Pardo, J.D.; Casado, J.; Escudero-Feliu, J.; Khaldy, H.; Arnedo, J.; Carazo, Á.; León, J.
Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer. Antioxidants 2023, 12, 926.
https://doi.org/10.3390/antiox12040926
AMA Style
Moreno-SanJuan S, Puentes-Pardo JD, Casado J, Escudero-Feliu J, Khaldy H, Arnedo J, Carazo Á, León J.
Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer. Antioxidants. 2023; 12(4):926.
https://doi.org/10.3390/antiox12040926
Chicago/Turabian Style
Moreno-SanJuan, Sara, Jose D. Puentes-Pardo, Jorge Casado, Julia Escudero-Feliu, Huda Khaldy, Javier Arnedo, Ángel Carazo, and Josefa León.
2023. "Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer" Antioxidants 12, no. 4: 926.
https://doi.org/10.3390/antiox12040926
APA Style
Moreno-SanJuan, S., Puentes-Pardo, J. D., Casado, J., Escudero-Feliu, J., Khaldy, H., Arnedo, J., Carazo, Á., & León, J.
(2023). Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer. Antioxidants, 12(4), 926.
https://doi.org/10.3390/antiox12040926